Bamco Has Cut Its Norwegian Cruise Line Hldgs (NCLH) Stake by $2.90 Million; Stock Declined; Gilead Sciences Co. (GILD) Holder Oakwood Capital Management Has Trimmed Position by $744,435 as Market Value Rose

April 22, 2018 - By Henry Gaston

Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) Logo

Oakwood Capital Management Llc decreased its stake in Gilead Sciences Co. (GILD) by 20.84% based on its latest 2017Q4 regulatory filing with the SEC. Oakwood Capital Management Llc sold 10,485 shares as the company’s stock rose 1.93% while stock markets declined. The institutional investor held 39,830 shares of the health care company at the end of 2017Q4, valued at $2.85 million, down from 50,315 at the end of the previous reported quarter. Oakwood Capital Management Llc who had been investing in Gilead Sciences Co. for a number of months, seems to be less bullish one the $96.09B market cap company. The stock decreased 0.99% or $0.74 during the last trading session, reaching $73.7. About 4.23 million shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 9.79% since April 22, 2017 and is uptrending. It has underperformed by 1.76% the S&P500.

Bamco Inc decreased its stake in Norwegian Cruise Line Hldgs (NCLH) by 5.49% based on its latest 2017Q4 regulatory filing with the SEC. Bamco Inc sold 54,679 shares as the company’s stock declined 2.15% with the market. The institutional investor held 941,867 shares of the marine transportation company at the end of 2017Q4, valued at $50.15M, down from 996,546 at the end of the previous reported quarter. Bamco Inc who had been investing in Norwegian Cruise Line Hldgs for a number of months, seems to be less bullish one the $12.46 billion market cap company. The stock increased 1.26% or $0.69 during the last trading session, reaching $55.65. About 1.41M shares traded. Norwegian Cruise Line Holdings Ltd. (NASDAQ:NCLH) has risen 3.63% since April 22, 2017 and is uptrending. It has underperformed by 7.92% the S&P500.

Investors sentiment decreased to 0.8 in Q4 2017. Its down 0.23, from 1.03 in 2017Q3. It worsened, as 95 investors sold GILD shares while 545 reduced holdings. 104 funds opened positions while 411 raised stakes. 972.68 million shares or 1.57% more from 957.62 million shares in 2017Q3 were reported. Tiverton Asset Mngmt Lc reported 76,778 shares. Mitsubishi Ufj Securities Holdings Limited reported 1,860 shares or 0.56% of all its holdings. Aperio Group Limited Liability Company holds 970,482 shares or 0.36% of its portfolio. Walter Keenan Consulting Mi Adv owns 6,170 shares. Moreover, Altavista Wealth Mgmt has 0.11% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Tower Bridge Advsrs holds 0.02% or 3,219 shares in its portfolio. Bryn Mawr stated it has 119,971 shares or 0.47% of all its holdings. Associated Banc holds 51,780 shares or 0.2% of its portfolio. Renaissance Tech Ltd accumulated 7.56M shares or 0.6% of the stock. Retirement Sys Of Alabama owns 1.05 million shares for 0.36% of their portfolio. Moreover, M Securities has 0.26% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Compton Mgmt Ri reported 1.86% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Piedmont Inv Advsrs Lc has invested 0.41% in Gilead Sciences, Inc. (NASDAQ:GILD). Wendell David Assoc reported 35,168 shares. Matrix Asset Ny owns 239,715 shares for 2.73% of their portfolio.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 126 analyst reports since July 29, 2015 according to SRatingsIntel. The stock has “Buy” rating by Jefferies on Tuesday, October 25. The firm has “Outperform” rating by Oppenheimer given on Wednesday, July 29. The rating was maintained by Mizuho with “Buy” on Tuesday, July 25. Piper Jaffray upgraded the stock to “Overweight” rating in Thursday, November 5 report. Leerink Swann maintained the shares of GILD in report on Wednesday, February 7 with “Market Perform” rating. The company was maintained on Tuesday, March 6 by Barclays Capital. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Buy” rating by Jefferies on Tuesday, September 6. The firm earned “Overweight” rating on Friday, July 24 by Piper Jaffray. The stock has “Buy” rating by Mizuho on Monday, February 5. Mizuho maintained the stock with “Buy” rating in Monday, February 12 report.

Since January 2, 2018, it had 0 buys, and 18 insider sales for $39.95 million activity. On Wednesday, February 21 Washington Robin L sold $401,566 worth of Gilead Sciences, Inc. (NASDAQ:GILD) or 5,000 shares. On Thursday, March 1 MARTIN JOHN C sold $3.93M worth of Gilead Sciences, Inc. (NASDAQ:GILD) or 50,000 shares. The insider Cogan John Francis sold 5,833 shares worth $437,588. Meyers James R sold 100,000 shares worth $8.02M. WILSON GAYLE E sold $4.68 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) on Friday, February 9.

Oakwood Capital Management Llc, which manages about $705.78 million and $451.74 million US Long portfolio, upped its stake in Ishr S&P 500 Index (IVV) by 4,261 shares to 10,922 shares, valued at $2.94M in 2017Q4, according to the filing. It also increased its holding in Dfa Global Real Estate Fund (DFGEX) by 39,025 shares in the quarter, for a total of 764,084 shares, and has risen its stake in Dfa Enhanced Us Lrg Co Port.

Analysts await Gilead Sciences, Inc. (NASDAQ:GILD) to report earnings on May, 1 after the close. They expect $1.59 earnings per share, down 27.73% or $0.61 from last year’s $2.2 per share. GILD’s profit will be $2.07 billion for 11.59 P/E if the $1.59 EPS becomes a reality. After $1.60 actual earnings per share reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts -0.63% negative EPS growth.

Bamco Inc, which manages about $24.24 billion and $21.69B US Long portfolio, upped its stake in Sasol Ltd (NYSE:SSL) by 162,211 shares to 619,954 shares, valued at $21.21M in 2017Q4, according to the filing. It also increased its holding in Intuitive Surgical Inc (NASDAQ:ISRG) by 18,038 shares in the quarter, for a total of 27,720 shares, and has risen its stake in Electronic Arts Inc (NASDAQ:EA).

Among 22 analysts covering Norwegian Cruise Line (NASDAQ:NCLH), 16 have Buy rating, 1 Sell and 5 Hold. Therefore 73% are positive. Norwegian Cruise Line had 58 analyst reports since August 5, 2015 according to SRatingsIntel. The rating was downgraded by UBS to “Neutral” on Wednesday, October 5. The stock of Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) has “Buy” rating given on Wednesday, July 20 by Stifel Nicolaus. The stock of Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) has “Buy” rating given on Tuesday, June 7 by Sterne Agee CRT. The firm has “Buy” rating by Nomura given on Wednesday, August 10. The stock has “Overweight” rating by JP Morgan on Monday, February 5. The firm earned “Buy” rating on Thursday, March 17 by SunTrust. The rating was maintained by UBS with “Buy” on Friday, August 12. SunTrust maintained the stock with “Buy” rating in Thursday, February 22 report. Barclays Capital maintained it with “Overweight” rating and $67 target in Friday, November 10 report. The company was downgraded on Wednesday, December 9 by Goldman Sachs.

Analysts await Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) to report earnings on May, 2 before the open. They expect $0.54 EPS, up 35.00% or $0.14 from last year’s $0.4 per share. NCLH’s profit will be $120.93M for 25.76 P/E if the $0.54 EPS becomes a reality. After $0.68 actual EPS reported by Norwegian Cruise Line Holdings Ltd. for the previous quarter, Wall Street now forecasts -20.59% negative EPS growth.

Since March 2, 2018, it had 0 insider purchases, and 2 insider sales for $1.09 billion activity.

Investors sentiment decreased to 1.34 in 2017 Q4. Its down 0.48, from 1.82 in 2017Q3. It fall, as 36 investors sold NCLH shares while 107 reduced holdings. 79 funds opened positions while 112 raised stakes. 202.66 million shares or 0.99% more from 200.67 million shares in 2017Q3 were reported. California State Teachers Retirement System reported 0.03% of its portfolio in Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH). Quantbot Technologies Limited Partnership holds 0.14% of its portfolio in Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) for 28,961 shares. Caisse De Depot Et Placement Du Quebec invested in 0% or 21,390 shares. Mufg Americas Holdings Corporation holds 0% or 280 shares. Toronto Dominion Savings Bank invested 0.01% in Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH). United Capital Advisers Ltd Llc has 17,008 shares. Ngam Advisors LP stated it has 73,725 shares. Ubs Asset Mngmt Americas stated it has 1.26 million shares or 0.06% of all its holdings. Twin Tree Mgmt Limited Partnership holds 0% or 3,573 shares in its portfolio. Garnet Equity Holdings Inc stated it has 2.13% in Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH). Dekabank Deutsche Girozentrale stated it has 0.01% of its portfolio in Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH). Invsts holds 0.62% of its portfolio in Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) for 10.37M shares. Mirae Asset Global Invests invested in 13,000 shares or 0.01% of the stock. Apollo Mngmt Holding LP reported 25.48 million shares stake. Los Angeles Mngmt And Equity Rech invested 0.04% of its portfolio in Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH).

Gilead Sciences, Inc. (NASDAQ:GILD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: